PHAR
Pharming Group

905
Mkt Cap
$785.18M
Volume
2,402.00
52W High
$17.08
52W Low
$7.31
PE Ratio
-122.13
PHAR Fundamentals
Price
$13.10
Prev Close
$13.41
Open
$13.08
50D MA
$14.30
Beta
0.39
Avg. Volume
14,971.00
EPS (Annual)
-$0.1761
P/B
4.04
Loading...
Loading...
Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONEST®, Joenja®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Pharming Group N.V. - ADR?
What is the 52-week high for Pharming Group N.V. - ADR?
What is the 52-week low for Pharming Group N.V. - ADR?
What is Pharming Group N.V. - ADR stock price today?
What was Pharming Group N.V. - ADR stock price yesterday?
What is the PE ratio of Pharming Group N.V. - ADR?
What is the Price-to-Book ratio of Pharming Group N.V. - ADR?
What is the 50-day moving average of Pharming Group N.V. - ADR?

Latest PHAR News

View

Advertisement|Remove ads.

Advertisement|Remove ads.